Finance

Results: 3469-3480 of 34442

Apollo Therapeutics’ Anti-IL-18 Antibody Camoteskimab Met the Primary Endpoint in a Double-Blind, Randomized, Placebo-Controlled Phase 2a Clinical Trial in Atopic Dermatitis

ACCESS Newswire associated0

U.S. Polo Assn. Celebrates Sport and Style as Official Apparel Sponsor of the 2025 Engel & Völkers Berlin Maifeld Polo Cup

ORQO Group Launches as Unified Digital Asset Management Platform

PR Newswire associated0

ALCOR Scientific Transforms ESR Testing: Extends Blood Sample Stability from 4 to 28 Hours

PR Newswire associated0

Caristo Congratulates Abcentra for First Patient Dosed Successfully in Phase 2b 'FORTIFY' Clinical Trial Evaluating Orticumab in Patients with Cardiovascular Disease

Business Wire logo

Areteia Therapeutics Announces Positive Topline Results from the First Phase III Study of Oral Dexpramipexole in Eosinophilic Asthma

Business Wire logo

Northern Trust Appoints Jessica Donohue as Global Head of Product Management for Asset Servicing

PR Newswire associated0

Miami International Holdings Launches Next-Generation Options Trading Floor in Miami

International SOS and SAF Aerogroup Announce Strategic Alliance to Deliver Seamless Aerial Medical Evacuation Services

PR Newswire associated0

KuCoin Congratulates Global Brand Ambassador Adam Scott on His Performance at the BMW PGA Championship

PR Newswire associated0

The Upcoming 8th CIIE: Countdown to Global Opportunities and Collaboration

QuestionPro and Day One Strategy Release 2025 Clinician AI Readiness Survey